PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18053628-1	2008	INTRODUCTION: Previous studies have evaluated the effect of modafinil on residual excessive daytime sleepiness (EDS) in patients with obstructive sleep apnea syndrome (OSAS) under effective CPAP treatment.	Modafinil	60-69	centromere protein J	Homo sapiens	190-194	
18053628-15	2008	CONCLUSION: In summary, our study confirms that modafinil used adjunctively with CPAP therapy improves subjective daytime sleepiness in patients with OSAS who were regular users of CPAP therapy but still experienced sleepiness.	Modafinil	48-57	centromere protein J	Homo sapiens	181-185	
25979103-1	2015	STUDY OBJECTIVES: To perform a meta-analysis of the effect of wakefulness-promoting agents (modafinil and armodafinil) in patients with residual sleepiness after CPAP therapy for obstructive sleep apnea.	Modafinil	92-101	centromere protein J	Homo sapiens	162-166	
25979103-1	2015	STUDY OBJECTIVES: To perform a meta-analysis of the effect of wakefulness-promoting agents (modafinil and armodafinil) in patients with residual sleepiness after CPAP therapy for obstructive sleep apnea.	Modafinil	106-117	centromere protein J	Homo sapiens	162-166